Hospital – Wound Treatment: Trionic® Algoderm Trionic®
Trionic®; (Europe) Algoderm Trionic® (Japan)
Bioactive Medical Device for Wound Therapy and Haemostasis
A Class III Product (Medical Device European Regulation) Suitable for deep wounds that reach the bone.
Embedded in a hydroactive biopolymer matrix, Manganese, Zinc, Calcium ions, accelerate biological wound healing processes in all phases.
Those important enzyme co-factors are released in a controlled manner via ion exchange and migrate into cells involved in tissue regeneration.
Trionic® (Europe) Algoderm Trionic® (Japan) are effective to stimulate the blood clotting and wound healing.
-
Trionic brochure downloadDownload the document
Bioactive Medical Device for Wound Therapy and Haemostasis
Cell-active effects in all phases of wound healing.
Proven Biological Effects
Trionic® activates cells by providing manganese, zinc, and calcium at the cellular level. These crucial enzyme co-factors are released in a controlled manner through ion exchange and migrate into cells involved in tissue regeneration.
- Trionic increases fibroblast density by 50%.
- Trionic increases collagen production (Type III) by 400%.
- Trionic increases collagen production (Type I) by 300%.
Three components create haemostatic action:
- Calcium ions (coagulation factor IV) accelerates platelet aggregation.
- The 3D fibre structure promotes platelet activation.
- The Trionic alginate matrix enhances coagulation.
Explore Trionic’s mechanism of action
Indications:
Chronic wounds (e.g., diabetic foot, pressure sores, leg ulcers), traumatically caused wounds (e.g., intra- and postoperative bleeding, burns, surgical wounds), deep wounds, and wound cavities.
Available in four sizes:
Trionic 5 cm x 5 cm (TRI 300)
Trionic 9.5 cm x 9.5 cm (TRI 301)
Trionic 10 cm x 20 cm (TRI 302)
Trionic Rope 30 cm (TRI 303)
Data on file.